Document is current
Any future updates will be listed below
-
Authors
Raimondi, Alessandra
Corallo, Salvatore
Lonardi, Sara
Antoniotti, Carlotta
Rimassa, Lorenza
Amatu, Alessio
Tampellini, Marco
Racca, Patrizia
Murialdo, Roberto
Clavarezza, Matteo
Zaniboni, Alberto
Toscano, Giuseppe
Tomasello, Gianluca
Petrelli, Fausto
Antonuzzo, Lorenzo
Giordano, Monica
Cinieri, Saverio
Longarini, Raffaella
Niger, Monica
Antista, Maria
Ambrosini, Margherita
Pagani, Filippo
Prisciandaro, Michele
Randon, Giovanni
de Braud, Filippo
Di Bartolomeo, Maria
Pietrantonio, Filippo https://orcid.org/0000-0002-8530-8420
Morano, Federica
-
Funding
Funding for this research was provided by:
This was an academic study. A research grant and drug supply during panitumumab-based maintenance treatment was provided by Amgen
- License Information
-
More Information
Article History
Received: 8 October 2020
Accepted: 22 December 2020
First Online: 3 January 2021
Compliance with ethical standards
:
: FP has received honoraria for speaker activities and participation in advisory boards from Sanofi, Amgen, Bayer, Merck-Serono, Lilly, Roche, Servier, and research grants from BMS.SL has received honoraria for speaker activities and participation in advisory boards from Amgen, Bayer, Merck-Serono, Roche, Servier, and Bristol Myers Squibb.LR has received honoraria for speaker activities and participation in advisory boards from AstraZeneca, AbbVie, Amgen, ArQule, Basilea, Bayer, Celgene, Eisai, Exelixis, Gilead, Hengrui Therapeutics, Incyte, Ipsen, Lilly, Merck Sharp & Dohme, Nerviano Medical Sciences, Roche, Sanofi, and research grants to her Institution from Agios, ARMO BioSciences, AstraZeneca, BeiGene, Eisai, Lilly, Exelixis, FibroGen, Incyte, Ipsen, Merck Sharp & Dohme, and Roche.PR has received honoraria for speaker activities and participation in advisory boards from Servier, Amgen, Roche, and Merck.AZ has received honoraria for speaker bureau from Sanofi, Amgen, Bayer, Merck-Serono, Lilly, Servier, and Bayer.MDB has received honoraria for speaker activities and participation in advisory boards from Amgen, Roche, Lilly, Servier, Incyte, and Celgene.FM has received honoraria for speaker activities from Servier.FDB has received honoraria for speaker activities and participation in advisory boards from Amgen, Roche, and Novartis. All other authors declared no disclosures.
: The study was conducted in accordance with the Declaration of Helsinki and the Good Clinical Practice. Institutional review board and Ethics committee approval was obtained from all participating centers.
: All patients provided written informed consent before any study-related procedures.
: Yes
: On request
